Pathological Complete Response After Neoadjuvant Therapy in Rectal Adenocarcinoma: a 5-Year Follow-up
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
https://link.springer.com/content/pdf/10.1007/s12262-021-02945-5.pdf
Reference33 articles.
1. National Cancer Registry, National Cancer Institute (2018) Malaysian study on cancer survival (MySCan). Ministry of Health Malaysia, Kuala Lumpur
2. Phang PT, Wang X (2014) Current controversies in neoadjuvant chemoradiation of rectal cancer. Surg Oncol Clin N Am 23(1):79–92. https://doi.org/10.1016/j.soc.2013.09.008
3. Torok JA, Palta M, Willett CG, Czito BG (2016) Nonoperative management of rectal cancer. Cancer 122(1):34–41. https://doi.org/10.1002/cncr.29735
4. Dedemadi G, Wexner SD (2012) Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate? Dig Dis 30(Suppl 2):109–117. https://doi.org/10.1159/000342039
5. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740. https://doi.org/10.1056/NEJMoa040694
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy;ANZ Journal of Surgery;2024-03-15
2. Clinical and pathological parameters predicting pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer;The Egyptian Journal of Surgery;2024-01
3. The Predictors of Complete Pathologic Response in Rectal Cancer during the Total Neoadjuvant Therapy Era: A Systematic Review;Cancers;2023-12-15
4. Characteristics of pathologic complete response for locally advanced rectal cancer;The American Journal of Surgery;2023-12
5. Analysis of Survival in Complete Pathological Response after Long-Course Chemoradiotherapy in Patients with Advanced Rectal Cancer;Current Oncology;2023-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3